Methyldopa anhydrous en es it fr

Methyldopa anhydrous Brand names, Methyldopa anhydrous Analogs

Methyldopa anhydrous Brand Names Mixture

  • No information avaliable

Methyldopa anhydrous Chemical_Formula

C56H71N9O23S

Methyldopa anhydrous RX_link

http://www.rxlist.com/cgi/generic4/mycamine.htm

Methyldopa anhydrous fda sheet

Methyldopa_anhydrous FDA

Methyldopa anhydrous msds (material safety sheet)

Methyldopa_anhydrous MSDS

Methyldopa anhydrous Synthesis Reference

No information avaliable

Methyldopa anhydrous Molecular Weight

1270.28 g/mol

Methyldopa anhydrous Melting Point

No information avaliable

Methyldopa anhydrous H2O Solubility

Freely soluble as sodium salt (> 200mg/mL)

Methyldopa anhydrous State

Solid

Methyldopa anhydrous LogP

No information avaliable

Methyldopa anhydrous Dosage Forms

Powder for solution (for injection)

Methyldopa anhydrous Indication

For use in the treatment of patients with esophageal candidiasis and prophylaxis of Candida infections in patients undergoing hematopoietic stem cell transplantation.

Methyldopa anhydrous Pharmacology

Formerly known as FK463, micafungin is a novel antifungal agent. It is a glucan synthesis inhibitor of the echinocandin structural class. The U.S. Food and Drug Administration approved micafungin in March 2005. Micafungin inhibits an enzyme essential for fungal cell-wall synthesis and is fungicidal (lethal) for Candida. Micafungin can be used concomitantly with a variety of other drugs, including the HIV protease inhibitor ritonavir and the transplant medications cyclosporine and tacrolimus.

Methyldopa anhydrous Absorption

No information avaliable

Methyldopa anhydrous side effects and Toxicity

Intravenous LD50 in rats is 125mg/kg. In dogs it is >200mg/kg. No cases of overdosage have been reported. Repeated daily doses up to 8 mg/kg (maximum total dose of 896 mg) in adult patients have been administered in clinical trials with no reported dose-limiting toxicity. The minimum lethal dose is 125 mg/kg in rats, equivalent to 8.1 times the recommended human clinical dose for esophageal candidiasis based on body surface area comparisons.

Methyldopa anhydrous Patient Information

No information avaliable

Methyldopa anhydrous Organisms Affected

Aspergillis, Candida and other fungi